Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Stands to Pocket $10M in Stock Offering

NEW YORK (GenomeWeb News) — CombiMatrix today said it stands to pocket $10 million when its parent company Acacia Research received commitments from “a select group of investors” to buy 9.8 million units of equity for $1.02 apiece
 
Each unit includes one Acacia Research-CombiMatrix share and a five-year warrant to buy 1.2 million shares at $.87 apiece. In afternoon trading today the stock was priced at $.88. The placement was handled by Oppenheimer & Co.
 
Acacia did not disclose how CombiMatrix plans to use the funding but said the firm is developing a platform to make semiconductor-based arrays for “identifying and determining roles of genes, gene mutations, and proteins.”

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more